1. Design of a patient‐ and investigator‐blind, randomized, placebo‐controlled study to evaluate efficacy, safety, and tolerability of bepranemab, UCB0107, in prodromal to mild Alzheimer's disease: The TOGETHER Study, AH0003. (31st December 2021) Authors: Barton, Matthew E; Byrnes, William; Mesa, Irene Rebollo; Bloemers, Jos; Maguire, Ralph Paul; Bouw, Rene; Tesseur, Ina; Ewen, Colin; Scheltens, Philip Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗